{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:06Z","timestamp":1761919746844},"reference-count":30,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.encep.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T21:37:38Z","timestamp":1384378658000},"page":"439-444","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enjeux cliniques du passage d\u2019un antipsychotique \u00e0 l\u2019autre"],"prefix":"10.1016","volume":"39","author":[{"given":"\u00c9.","family":"Constant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2013.10.001_bib0005","first-page":"10","article-title":"Predictors of switching antipsychotics medications in the treatment of schizophrenia","author":"Nyhuis","year":"2010","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2013.10.001_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2005-864122","article-title":"Reasons for switching between antipsychotics in daily clinical practice","volume":"38","author":"Hugenholtz","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.encep.2013.10.001_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002130050901","article-title":"Clozapine as a drug of dependence","volume":"142","author":"Goudie","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl. 2","key":"10.1016\/j.encep.2013.10.001_bib0020","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.001_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.2006.00787.x","article-title":"Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse","volume":"114","author":"Moncrieff","year":"2006","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.encep.2013.10.001_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/JCP.0b013e3180a9076c","article-title":"Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study","volume":"27","author":"Kim","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2013.10.001_bib0035","first-page":"64","article-title":"Open labeled, randomized switch-over study of two fixed doses (10\/15mg) of aripiprazole: to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia","volume":"46","author":"Sarin","year":"2004","journal-title":"Indian J Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2013.10.001_bib0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.2011.10111609","article-title":"A randomised trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)","volume":"168","author":"Stroup","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.encep.2013.10.001_bib0045","first-page":"16","article-title":"Extrapyramidal side effects: tardive dyskinesia, and the concept of atypicity","volume":"61","author":"Glazer","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2013.10.001_bib0050","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2\u00a0high states implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.encep.2013.10.001_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00464798","article-title":"Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal","volume":"83","author":"Ekblom","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.encep.2013.10.001_bib0060","first-page":"755","article-title":"A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis","volume":"25","author":"Fallon","year":"2011","journal-title":"J Pharmacol"},{"issue":"11","key":"10.1016\/j.encep.2013.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.135.11.1409","article-title":"Neuroleptic-induced supersensitivity psychosis","volume":"135","author":"Chouinard","year":"1978","journal-title":"Am J Psychiatry"},{"issue":"1-2","key":"10.1016\/j.encep.2013.10.001_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00431719","article-title":"Early relapse after sudden withdrawal or dose reduction of clozapine","volume":"86","author":"Perenyi","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.encep.2013.10.001_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4088\/JCP.v59n0906","article-title":"Clozapine withdrawal-emergent dystonias and dyskinesias: a case series","volume":"59","author":"Ahmed","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2013.10.001_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-200208000-00003","article-title":"Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder","volume":"22","author":"Margolese","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2013.10.001_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000112883","article-title":"Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes","volume":"77","author":"Chouinard","year":"2008","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.encep.2013.10.001_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0079-6468(10)49002-5","article-title":"A decade of progress in the discovery and development of \u201catypical\u201d antipsychotics","volume":"49","author":"MacDonald","year":"2010","journal-title":"Prog Med Chem"},{"issue":"7","key":"10.1016\/j.encep.2013.10.001_bib0095","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.pnpbp.2007.07.007","article-title":"Olanzapine withdrawal\/discontinuation-induced hyperthermia in rats","volume":"31","author":"Goudie","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.001_bib0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.encep.2013.10.001_bib0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/ajp.137.11.1395","article-title":"The role of choliergic supersensitivity in the medial symptoms associated with withdrawal of antipsychotic drugs","volume":"137","author":"Luchins","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.001_bib0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2013.10.001_bib0115","first-page":"4","article-title":"Strategies for dosing and switching antipsychotics for optimal clinical management","volume":"69","author":"Buckley","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.001_bib0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145705005328","article-title":"Combined alpha2\u00a0and D2\/3\u00a0receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat","volume":"8","author":"Marcus","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2013.10.001_bib0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpsyc.1997.01830130055011","article-title":"Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment","volume":"54","author":"Viguera","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.001_bib0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2008.09.031","article-title":"Does switching to a new antipsychotic improve ourcomes? Data from the CATIE trial","volume":"107","author":"Rosenheck","year":"2009","journal-title":"Schizophr Res"},{"issue":"11","key":"10.1016\/j.encep.2013.10.001_bib0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4088\/JCP.v61n1105","article-title":"Strategies for switching from conventional antipsychotics drugs or risperidone to olanzapine","volume":"61","author":"Kinon","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2013.10.001_bib0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pnpbp.2004.01.019","article-title":"Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia","volume":"28","author":"Mori","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Suppl. 12","key":"10.1016\/j.encep.2013.10.001_bib0145","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders: introduction, methods, commentary, and summary","volume":"64","author":"Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2013.10.001_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200519010-00003","article-title":"Switching between second-generation antipsychotics: why and how?","volume":"19","author":"Edinger","year":"2005","journal-title":"CNS Drugs"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061300225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061300225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:16:09Z","timestamp":1564686969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370061300225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S001370061300225X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2013.10.001","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enjeux cliniques du passage d\u2019un antipsychotique \u00e0 l\u2019autre","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 L\u2019Enc\u00e9phale, Paris. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}